Omniabincis A Biotechnology Company Focused On Discovering And Developing Therapeutic Antibodiesthe Company Employs A Proprietary Discovery Platform That Combines High Throughput Screening Technologies With A Diverse Antibody Repertoirethis Innovative Approach Utilizes Transgenic Animal Speciessuch As Omniratomnimouseand Omnichickenwhich Are Engineered To Produce Human Sequence Antibodiesstreamlining The Early Stages Of Drug Discovery Omniab Provides A Range Of Services And Technologies For Therapeutic Antibody Discoverytheir Platform Includes Transgenic Animal Models That Generate Fully Human Antibodieshigh Throughput Screening For Identifying Therapeutic Candidatesand Biological Intelligence That Enhances The Immune Systems Of Their Engineered Animalsadditionallyomniab Utilizes Omnideepa Suite Of Ai And Machine Learning Toolsto Optimize Therapeutic Discoverythe Company Collaborates With Over 90 Biopharmaceutical Companies And Research Institutions Globallyfacilitating Advancements In Clinical Drug Development And Reducing The Timeline And Costs Associated With Bringing New Therapies To Market
